HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Alzheimer's patient shows improvement after experimental drug

Created at 4 Jun · 2:26 PM1 source↑ Market-relevant
IN SHORT

An Alzheimer's patient with advanced disease experienced gains in speech, continence, and memory after receiving 5 grams of an experimental hallucinogen.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

5 gramsexperimental drug dosage

Who's Involved

Alzheimer's patient
received experimental drug and showed improvement

↳ Why This Matters

This case suggests a potential new avenue for treating advanced Alzheimer's disease, offering hope for patients and families affected by the condition.

Key facts

  • An Alzheimer's patient with advanced disease showed improvement.
  • The patient experienced gains in speech, continence, and memory.
  • The improvement followed the administration of an experimental drug.
  • A dose of 5 grams of the drug was administered.

A patient suffering from advanced Alzheimer's disease has reportedly regained speech, continence, and memory after being treated with a high dose of an experimental drug. The patient received 5 grams of the substance, which is described as an experimental hallucinogen. The improvements observed are considered remarkable given the advanced stage of the disease.

Frequently asked questions

The patient showed improvements in speech, continence, and memory.

The patient received 5 grams of an experimental drug, described as a hallucinogen.

The patient had advanced Alzheimer's disease.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

4 Jun · 2:05 PM
An Alzheimer's patient experienced significant improvements in speech, continence, and memory after receiving a high dose of an experimental drug.
New York Post via PiQSuite

Sources

T1
Alzheimer's patient gets back speech, continence and memory after 5 grams of experimental drugm.piqsuite.com

Related Stories

SpaceXAI Launches Grok 4.5 AI Model, Intensifying Rivalry with OpenAI
8 Jul · 11:00 AM
Daniel Hulme: I asked Elon Musk on a yacht to help me solve AI consciousness
9 Jul · 4:50 AM
Google's SynthID debunks AI-generated Mitch McConnell hoax image
8 Jul · 8:45 PM
Lawsuit: Grok user created 7K child sex images; xAI accused of obstructing probe
8 Jul · 8:05 PM
Nvidia CEO Jensen Huang: Engineers prefer building AI agents to coding
9 Jul · 5:35 AM